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Abstract
Background: Cerebral vasospasm (CVS) is a common serious complication after the spontaneous subarachnoid
hemorrhage (SAH). Despite recent advances in medical and surgical treatments, the 30-day mortality rate of SAH
remains high, and there is lack of especially effective clinical treatment to alleviate and improve CVS. The present
study has investigated the therapeutic effect of insulin and vitamin C on CVS after SAH.
Results: Five days after SAH, there is obvious basilar artery spasm in SAH group, whose average vascular cross-
sectional area (233,099 ± 16,750 μm
2) is significantly smaller than that in control group (462,128 ± 74,756 μm
2),
which is also significantly different from those in SAH + insulin group (221,114 ± 43,457 μm
2) and SAH + vitamin C
group (237,820 ± 21,703 μm
2). SAH + insulin + vitamin C group shows no evident vasospasm and maintains a
vascular cross-sectional area of 425,530 ± 45,503 μm
2, which is significantly different from that in SAH group.
Insulin receptor a (InRa) expression is significantly downregulated in the vascular endothelial cells of SAH, SAH +
insulin, and SAH + vitamin C groups (P < 0.01) but remains unchanged in vascular endothelial cells of SAH +
insulin + vitamin C group (P > 0.05). Five days after SAH, serum and cerebrospinal fluid NO levels in SAH, SAH +
insulin, and SAH + vitamin C groups decrease significantly (P < 0.01) compared to that in control group, whereas
the reduction is not evident in SAH + insulin + vitamin C group (P > 0.05).
Conclusion: Combinatorial treatment with insulin and vitamin C has effectively relieved the CVS after SAH in
rabbit, possibly through increasing the InRa expression and NO level, whereas treatment with insulin or vitamin C
alone fails to do so.
Background
CVS is a common serious complication after the sponta-
neous SAH. It induces and aggravates cerebral ischemic
injury and becomes one of the major causes of disability
and mortality after aneurysm rupture. Although some
medications like non-selective calcium blockers can be
administered, there is still lack of especially effective
clinical treatment to alleviate and improve CVS [1].
How to prevent and improve CVS is an urgent problem
facing the neurosurgeons. Studies have confirmed that
in addition to regulating metabolism, promoting cell
growth and proliferation, and inhibiting apoptosis, insu-
lin also plays a strong vasoactive role, dilates the vessels,
increases blood flow, and improves metabolism in tis-
sues [2]. The vasodilatory effect of insulin is achieved
through increasing the synthesis and release of NO in
vascular endothelial cells [3]. The post-SAH oxidation of
oxyhemoglobin into methemoglobin and the release of
large amount of oxygen free radicals cause serious injury
in endothelial cells, which becomes one of the major
mechanisms underlying the occurrence of CVS and the
brain damage. Although vitamin C cannot directly dilate
the blood vessels, it has powerful antioxidant effect to
remove and inhibit oxygen free radicals and to improve
the function of endothelial cells [4], thus may help insu-
lin in regulating blood vessels. Therefore, this study has
investigated the therapeutic effect of combinatorial use
of insulin and vitamin C in treatment of post-SAH CVS
in a rabbit model to provide experimental basis for
future clinical treatment.
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The cross-sectional area of basilar artery
The vascular cross-sectional area in SAH + insulin +
vitamin C group is 425,529.9 ± 45,502.98 μm
2,w h i c h
shows no significant difference from that in control
group (462,127.9 ± 74,755.82 μm
2, P =0 . 6 0 5 ) .T h ev a s -
cular cross-sectional areas in SAH, SAH + insulin, and
SAH + vitamin C groups are 233,099.2 ± 16,750.12 μm
2,
221,113.6 ± 43,456.86 μm
2, and 237,819.6 ± 21,703.01
μm
2, respectively, and all are significantly different from
that in control group (P < 0.01). There is significant dif-
ference between SAH + insulin + vitamin C group and
SAH group (P < 0.01, Table 1).
Immunohistochemistry
The expressions of InRa in basilar artery endothelial
cells in SAH, SAH + insulin, and SAH + vitamin C
groups are significantly lower than that in control group
(P < 0.01), whereas the InRa expression in endothelial
cells in SAH + insulin + vitamin C group has been sig-
nificantly increased and different from those in SAH +
insulin and SAH + vitamin C groups (P < 0.01, Table 1).
Hematoxylin and eosin (H&E) staining
Staining of the sections from SAH group shows signifi-
cant thickening of the basilar artery wall, shrinkage,
detachment, and falling off of the endothelial cells, man-
ifesting typical battlement-like changes (Figure 1B). SAH
+ insulin or SAH + vitamin C group shows evident ves-
sel wall thickening, battlement-like change, endothelial
cell shrinkage, and detachment (Figure 1C and 1D),
whereas combinatorial treatment group exhibits mild
thickening of the vessel wall and stretch of the endothe-
lial cells with rare or no detachment (Figure 1E).
NO content
In the fifth day after SAH, NO levels in serum and cere-
brospinal fluid decrease significantly (P < 0.01). After
combinatorial treatment with insulin and vitamin C, NO
level increases significantly in serum and cerebrospinal
fluid (P < 0.05), whereas insulin or vitamin C alone fails
to increase the NO level (P < 0.01, Figure 2).
Glucose and insulin contents
Serum glucose level in the animals shows significant
transient increase at 30 min after the blood injection,
which is significantly higher than the normal reference
value (P < 0.05), but exhibits no significant changes at
other times after the injection. Although serum insulin
increases at 30 min after the blood injection and
remains at a higher level, the difference is not significant
when compared to the original level before the blood
injection; however, the differences become significant at
the third and fifth days after the injection (P <0 . 0 5 ,
Table 2).
Discussion
In this study, combinatorial use of insulin and vitamin C
has successfully alleviated the CVS after SAH, though
individual administration of either insulin or vitamin C
fails to achieve the desired effects, which confirms the
destructive effect of oxygen free radicals on vascular
endothelial cells and the significant vasodilatory effect of
insulin. These results are consistent with those from
Hirashima et al. [4].
Insulin resistance is the state of tissues and organs
with reduced sensitivity to insulin. Previous studies have
confirmed that inhibition of insulin’s vasoactive effect
induces insulin resistance and hyperinsulinemia, which
is the major cause of atherosclerosis and coronary artery
spasm [5-7]. The present study has demonstrated that
one day after blood injection, the cross-sectional area of
basilar artery in experimental animals decreases signifi-
cantly with apparent constriction of the blood vessels,
which becomes mostly significant at the third day post
blood injection (that is the fifth day of the study),
relieves then gradually, and recovers at the fifth day.
Although the glucose level only increases within 30 min
after the blood injection, the plasma insulin level begins
to rise continuously 30 min after the injection and
reaches its maximum 5 days after the second injection,
implying that CVS is associated with hyperinsulinemia.
Experiments have confirmed that sustained high insulin
level may promote the pathological changes of blood
vessels, which forms an independent risk factor for
Table 1 Cross-sectional area of basilar artery (x ± SE ) and InRa expression on the endothelial cells
InRa expression Rank difference
Groups n Cross-sectional area (μm
2)0 1 2
Control 5 462127.9 ± 74755.82 0 0 5
SAH 10 233099.2 ± 16750.12* 8 2 0 24.80*
SAH + Vc 10 237819.6 ± 21703.01* 7 2 1 22.00*
SAH + In 10 221113.6 ± 43456.86* 6 4 0 21.60*
SAH + In + Vc 10 425529.9 ± 45502.98 0 3 7 3.60
In: insulin; Vc: vitamin C; *: P < 0.01 compared to control group;
Δ: P < 0.01 compared to SAH + In + Vc group; InRa expression: 0 (negative), 1 (positive), and 2
(strongly positive).
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downregulate insulin receptor by reducing the number
and expression of insulin receptor in vascular endothe-
lial cells, resulting in insulin resistance [8]; secondly,
hyperinsulinemia activates protein kinase C (PKC) and
abnormally increases its activity; thirdly, hyperinsuline-
mia promotes the proliferation of vascular smooth mus-
cle cells and the synthesis and secretion of endothelin-1
(ET-1) in endothelial cells [9]. These delayed pathophy-
siological changes are also characteristic in CVS after
SAH [1,10].
Therefore, according to the results of this study, it is
reasonable to speculate that insulin resistance also exists
in the present model of CVS after SAH. The number
and expression of insulin receptor on the membrane of
endothelial cells in the basilar artery with severe spasm
have been significantly reduced, whereas the expression
of insulin receptor on the endothelial cells of basilar
artery without spasm is strongly positive. Downregula-
tion of the number and expression of insulin receptor
causes insulin resistance and inhibition of the various
physiological effects of insulin, including its vasoactive
effect [8]. Vascular endothelial cells are the target cells
for insulin to exert its vascular regulatory effects. Exten-
sive studies have demonstrated that there are a large
number of insulin receptors on vascular endothelial
cells; upon binding with insulin, the downstream signal-
ing pathways are activated to further stimulate the pro-
duction of ET-1 and NO in endothelial cells, adjust the
balance of vascular constriction, and hence exert the
vasoactive effect [11]. However, as shown in this study,
the vascular endothelial cells are damaged after SAH;
the number and expression of insulin receptor on these
cells are reduced significantly, resulting in insufficient
binding with insulin and failure in promoting the release
of the vasodilatory factor NO, which hampers the
vasoactive effect of insulin. Therefore, treatment with
insulin alone fails to alleviate the CVS, whereas combi-
natorial use of insulin and vitamin C effectively relieve
the symptom. Vitamin C is an antioxidant; although
itself has no direct role on the vasomotor and hemody-
namics [4], vitamin C can counteract the damaging
Figure 1 H&E staining of basilar artery (Magnification: × 400). A (control group) shows spreading of endothelial cells and no thickening of
the vessel wall; B (SAH group) shows significant thickening of vessel wall and shrinkage of endothelial cells, manifesting battlement-like
morphological changes; C (SAH + insulin group) exhibits significant vessel wall thickening and endothelial cell shrinkage with battlement-like
changes too; D (SAH + vitamin C group) shows significant wall thickening and endothelial cell shrinkage, manifesting battlement-like changes; E
(SAH + insulin + vitamin C group) shows spreading of endothelial cells with moderate wall thickening.
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improve cell function, reduce insulin resistance, increase
the sensitivity to insulin in endothelial cells, promote
the binding of insulin with its receptor, and thereby
increase the release of vasodilatory factor NO to exert
its vasoactive effect. In addition, vitamin C can inhibit
t h ea c t i v i t yo fo x y g e nf r e er a d i c a l sa n di n h i b i tt h e i r
binding to NO, thus facilitating the vasodilatory effect of
NO [12,13]. Therefore, combinatorial use of insulin and
vitamin C has significantly improved CVS in animals of
SAH + insulin + vitamin C group.
However, the most serious complication of insulin
therapy is low blood glucose reaction. In this study, the
blood glucose has been controlled at a level higher than
4.9 mmol/L (the normal range of blood glucose level in
rabbit is 4.33 ~ 8.60 mmol/L), and there is no occur-
rence of twitch, coma, and other symptoms in the ani-
mals due to low blood glucose level.
Conclusions
The present study has successfully alleviated the post-
SAH CVS in rabbit through combinatorial treatment
with insulin and vitamin C. However, since the cerebral
vascular structures in human are significantly different
from that in rabbit, the effect of this method in treating
CVS in human needs further investigations.
Methods
The animal protocols in this study were approved by the
institutional Laboratory Animal Ethics Committee; all
the animals were treated humanely in accordance with
the guidelines for the Care and Use of laboratory Ani-
mals published by the U.S. National Institutions of
Health (NIH Publication No. 85-23, revised 1996).
Animals and the establishment of SAH model
Total 65 male New Zealand white rabbits, weighing 2.8
~ 3.1 kg, were purchased from Experimental Animal
Center of Jiangsu Province. Animals were rested for one
week in the animal laboratory of our hospital. Post-SAH
basilar artery spasm model was induced by two times of
intracisternal injection of autologous blood [14]. Briefly,
animals were anesthesized by intramuscular injection of
ketamine (25 mg/Kg) and droperidol (1.0 mg/Kg),
placed in lateral position, and covered with sterile surgi-
cal hole towel. Cisternal puncture was performed percu-
taneously with No. 7 lumbar puncture needle. After
drainage of 1 mL of cerebrospinal fluid, 1.5 mL fresh
blood were drawn rapidly from the central artery in rab-
bit ear and injected into the cistern magna within 20
seconds. After completing the blood injection, animals
were placed rapidly in head-low position at 30°C for
about 5 min to facilitate the blood dispersing in the
brain. The same procedure was repeated after 48 h. The
rectal temperature of animal was maintained at 37°C
with heated blankets.
The grouping and treatment of animals
Total 45 animals were randomly divided into 5 groups:
1) control group (n = 5) was injected with 1.5 mL saline
through cisternal puncture; 2) SAH group (n = 10)
received no treatment after the blood injection; 3) SAH
+ insulin group (n = 10) was treated by subcutaneous
Figure 2 NO contents in cerebrospinal fluid and serum.A
shows NO contents in cerebrospinal fluid, and B shows NO
contents in serum.
Table 2 Blood glucose and insulin levels (x ± SE) before
and after blood injection
Time Blood glucose (mmol/L) Insulin (IU)
Before injection 6.13 ± 0.65 13.46 ± 3.80
30 min 10.64 ± 2.83* 37.38 ± 9.57
60 min 7.64 ± 2.91 42.65 ± 9.60
90 min 6.36 ± 0.63 43.94 ± 12.37
SAH1D 6.72 ± 0.30 40.43 ± 7.79
SAH3D 7.75 ± 1.63 51.35 ± 16.83*
SAH5D 7.51 ± 2.12 67.15 ± 16.36*
30 min, 60 min, 90 min, SAH1D, SAH3D, and SAH5D: the times after blood
injection; *: P < 0.05 compared to control.
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blood injection, 3 times/d; 4) SAH + vitamin C group (n
= 10) was treated by intramuscular injection of vitamin
C at 40 mg/kg, starting 30 min after the blood injection,
3 times/d; 5) SAH + insulin + vitamin C group (n = 10)
was treated by subcutaneous injection of insulin at 0.2
U/kg plus intramuscular injection of vitamin C at 40
mg/kg, starting 30 min after the blood injection, 3
times/d. During the process of model induction, groups
with rabbits died from rapid increase in intracranial
pressure due to the blood injection were supplemented
randomly. The glucose level in ear blood and the beha-
vior of animals in insulin treated groups were monitored
2 h after insulin injection. All the animals were killed at
the fifth day after blood injection by perfusion. Another
20 rabbits were randomly divided into the following
four groups: 1) control group (n = 5) was injected intra-
cisternally with 1.5 mL saline; 2) SAH1D group (n = 5)
was killed one day after the blood injection; 3) SAH3D
group (n = 5) was killed three days after the blood injec-
tion; 4) SAH5D group (n = 5) was used for the mea-
surement of blood glucose and insulin levels; the blood
drawn from marginal vein of rabbit ear was tested for
glucose (with rapid glucometer) and insulin contents
respectively at 10 min before the puncture, at 30, 60,
and 90 min after the blood injection, as well as at 1 h
before each meal on the first, third, and fifth days after
the injection.
The perfusion
All animals were anasthesized by intramuscular injection
of ketamine (25 mg/kg) and droperidol (1.0 mg/kg),
placed in supine position, and fixed on the operating
table. Perfusion was carried out after drawing 2 mL
blood from ear vein and 2 mL cerebrospinal fluid from
each animal [15]. Briefly, 37°C neutral phosphate buffer
was firstly injected into the body through left ventricle
and replaced by 37°C 10% neutral formalin to fix the tis-
sues immediately after the effluence was in light color.
After perfusion, the brain tissues with basilar artery
were preserved in 10% neutral formalin and sent to the
Department of Pathology for further processing.
Specimen preparation and determination of the arterial
diameter
Samples were collected from the midpoint of proximal,
middle, and distal portions of the basilar artery respec-
tively, embedded, and cut into five consecutive 4 μm
sections by the staff in Department of Pathology, who
was double-blind for both the experimental design and
grouping. Sections were stained with H&E, and photo-
graphs at 4 × magnification were collected with high-
resolution medical image analysis system (HMIAP,
2000. Tongji Medical University, China). The inner
perimeters (L) of basilar arteries in each section were
measured with ImageJ software package (USA), and the
vascular cross-sectional area was calculated by Excel
software according to the formula S (cross-sectional
area) = πL
2/4.
The measurement of blood glucose and insulin
Blood glucose levels were measured with fast gluc-
ometer; serum insulin levels were determined by radio-
immunoassay method with Insulin RIA kit (Beijing
FuRui Biosciences, Beijing, China) following the manu-
facturer’s instructions.
Detection of NO
NO content was determined indirectly by colorimetry
m e t h o d .B r i e f l y ,o nt h ef i f t hd a yo fS A Hi n d u c t i o n ,2
mL of ear venous blood and 2 mL of cerebrospinal fluid
were collected and centrifuged at 3000 rpm, and the
supernatants were harvested for further NO detection
with the special kit provided by the Academy of Military
Medical Sciences (Beijing, China) following the manu-
facturer’s instructions.
Immunohistochemical staining
Immunohistochemical staining with mouse anti-insulin
receptor a antibody (Bioscience Company, USA) and
evaluation of insulin receptor a expression in basilar
artery endothelial cells were done by staff from the
Department of Pathology (under double-blind condi-
tion). The expression of insulin receptor a was classified
into three levels as the following: 0 (negative), 1 (posi-
tive), and 2 (strongly positive).
Statistics
The data of cross-sectional area, blood glucose, insulin,
and NO content were presented as mean ± standard
error (x ± SE) and analyzed with SPSS13.0 software
package (one-way ANOVA and followed by student t-
test). Endothelial expression of InRa among different
groups was analyzed using Mann-Whitney test. Differ-
ences with P < 0.05 were considered as significant.
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